Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
autoimmune, basket, bev, bevacizumab, Cambridge, cancellation, choice, CisGem, cisplatin, cORR, Cowen, debited, disagreement, durvalumab, Eastern, escalation, esophageal, expiry, gemcitabine, hematological, house, inflammatory, join, MTD, NY, oral, Organisation, preferential, primate, randomized, rationale, Renton, retired, Senate, stable, stimulation, subgroup, syndrome, TD, toxicology, unissued, uterine, webcast
Removed:
auristatin, biparatopic, cleavable, compound, cytotoxin, fixed, intention, maturity, mesothelioma, sudden
Filing tables
Filing exhibits
Related press release
Zymeworks similar filings
Filing view
External links